Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical business.
Related Posts
GM, Hyundai Explore Joint Car Development
The carmakers say the potential collaboration could help cut costs by teaming up on new models, including electric and hydrogen-powered vehicles.
Auto & Transport Roundup: Market Talk
Lufthansa, Allegiant Air and more in the latest Market Talks covering the Auto and Transport sector.
The Addiction to Discounting at Michael Kors Is Exposed in Court
The antitrust trial over Kors’s proposed merger with Coach-owner Tapestry shows how far the handbag maker has fallen.